Browse > Article
http://dx.doi.org/10.7318/KJFC/2022.37.2.143

Perception and Demand of Primary Caregivers and Clinical Experts for the Dietary Management of Children with Galactosemia in Korea  

Yim, Seojeong (Department of Nutritional Science and Food Management, Ewha Womans University)
Seo, Hyeji (Department of Nutritional Science and Food Management, Ewha Womans University)
Kim, Yuri (Department of Nutritional Science and Food Management, Ewha Womans University)
Oh, Jieun (College of Science and Industry Convergence, Ewha Womans University)
Publication Information
Journal of the Korean Society of Food Culture / v.37, no.2, 2022 , pp. 143-152 More about this Journal
Abstract
Galactosemia is a rare genetic metabolic disease caused by galactose and its metabolites generated during carbohydrate metabolism, which is relatively rare in Asian countries, including Korea. Patients with galactosemia should be treated with a galactose-restricted diet. However, information is lacking about the exact content of galactose in food, and dietary guidelines for patients with galactosemia in Korea. This study aims to recognize the difficulties faced by parents and clinical experts of patients with galactosemia, and understand their demands. Totally, 5 parents of children diagnosed with galactosemia and 5 clinical professionals participated in the focus group interviews. The parents' interview focused on the daily life of the patient, which included diet and social difficulties. The clinical experts mainly answered about medical care, including the number and status of patients, and their suggestions for effective treatment. Most parents were worried about social isolation due to conflicts in the family as well as in society due to a lack of understanding of the disease. The clinical experts stated the absence of a disease management system as the greatest problem. An integrated support system for patients with galactosemia, which includes appropriate dietary guidelines by considering the domestic environment, is required.
Keywords
Galactosemia, rare metabolic disease; dietary management; qualitative study;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Sarkar M, Bose SS, Mondal G, Chatterjee S. 2010. Generalized Epimerase Deficiency Galactosemia. Indian J. Pediatr., 77(8):909-910   DOI
2 Lee JA, Seo MA. 2019. Narrative inquiry on life experiences of mothers of children with rare diseases. Fam. & Fam. Ther., 27(1):1-26
3 Delnoy B, Coelho AI, Rubio-Gozalbo ME. 2021. Current and future treatments for classic galactosemia. J. Pers. Med., 11(2):75   DOI
4 Milankovics I, Schuler A, Kamory E, Csokay B, Fodor F, Somogyi C, Nemeth K, Fekete G. 2010. Molecular and Clinical Analysis of Patients with Classic and Duarte Galactosemia in Western Hungary. Wien. Klin. Wochenschr, 122(3):95-102   DOI
5 Sabatino JA, Starin D, Tuchman S, Ferreira C, Regier DS. 2019. Elevated Urine Oxalate and Renal Calculi in a Classic Galactosemia Patient on Soy-based Formula. JIMD reports, 49(1):7-10   DOI
6 Schadewaldt P, Kamalanathan L, Hammen H, Wendel U. 2004. Age Dependence of Endogenous Galactose Formation in Q188R Homozygous Galactosemic Patients. Mol. Genet. Metab., 81(1):31-44   DOI
7 Sohn YB. 2015. A Diagnostic Algorithm of Newborn Screening for Galactosemia. J. Korean Soc. Inherit. Metab. Dis., 15(3):101-109
8 Timson DJ. 2016. The Molecular Basis of galactosemia-Past, Present and Future. Gene, 589(2):133-141
9 Welling L, Bernstein LE, Berry GT, Burlina AB, Eyskens F, Gautschi M, Grunewald S, Gubbels CS, Knerr I, Labrune P. 2017. International Clinical Guideline for the Management of Classical Galactosemia: Diagnosis, Treatment, and Follow-Up. J. Inherit. Metab. Dis., 40(2):171-176   DOI
10 Australasian Society for Inborn Errors of Metabolism. Handbook for Galactosaemia 2010. https://www.hgsa.org.au/documents/item/50, [accessed 2022.03.02]
11 Galactosemia Foundation. Diet Guidelines. http://www.galactosemia.org, [accessed 2022.03.01]
12 Kim MK, Ju SJ, Kim KS. 2017. The Experiences of Developmental Disorder Child Mothers Who Participated in the Brain Growth Attachment Program. J. Wellness, 12(4):301-315
13 Dilshad RM, Latif MI. 2013. Focus group interview as a tool for qualitative research: An analysis. Pakistan J. Soc. Sci., 33(1):192
14 Guba EG, Lincoln YS. 1994. Competing paradigms in qualitative research. Handbook of qualitative res., 2:105
15 Hermans ME, Welsink-Karssies MM, Bosch AM, Oostrom KJ, Geurtsen GJ. 2019. Cognitive functioning in patients with classical galactosemia: A systematic review. Orphanet J. Rare. Dis., 14(1):1-11   DOI
16 The British Dietic Association. Use of Infant Formulas based on Soy Protein 2019. https://www.bda.uk.com/resource/useof-infant-formulas-based-on-soy-protein.html, [accssed 2022.03.16]
17 Health Insurance Review & Assessment Service. Healthcare Bigdata Hub. Disease Subdivision Statistics. http://opendata.hira.or.kr/op/opc/olap4thDsInfo.do, [accessed 2022.03.01]
18 Korea Disease Control and Prevention Agency. 2019. Annual Report on the Rare Patients in Korea 2019. https://helpline.kdca.go.kr/cdchelp/ph/ptlcontents/selectPtlConSent.do?schSno=145&menu=C0400, [accessed 2022.02.28]
19 Korea Disease Control and Prevention Agency. 2020. Annual Report on the Rare Patients in Korea 2020. https://helpline.kdca.go.kr/cdchelp/ph/ptlcontents/selectPtlConSent.do?schSno=145&menu=C0400, [accessed 2022.02.28]
20 Banford S, McCorvie TJ, Pey AL, Timson DJ. 2021. Galactosemia: towards pharmacological chaperones. J. Pers. Med., 11(2):106   DOI
21 Kim Bh, Kim KM, Park IS, Lee GJ, Kim JK, Hong JJ, Lee MH, Kim YH, Yoo IV, Lee HY. 1999. A comparison of phenomenological research methodology focused on Giorgi, Colaizzi, Van Kaam Methods. J. Korean Acad. Nurs., 29(6) 1208-1220   DOI
22 Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HS, Wijburg FA, Last BF. 2004. Living with classical galactosemia: health-related quality of life consequences. Pediatr., 113(5):423-428
23 Bosch AM, Maurice-Stam H, Wijburg FA, Grootenhuis MA. 2009. Remarkable Differences: The course of life of young adults with Galactosaemia and PKU. J. Inherit. Metab. Dis., 32(6):706-712   DOI
24 Carlock G, Fischer ST, Lynch ME, Potter NL, Coles CD, Epstein MP, Mulle JG, Kable JA, Barrett CE, Edwards SM. 2019. Developmental outcomes in duarte galactosemia. Pediatr., 143(1)
25 Ko D, Chang HE, Song SH, Park KU, Kim JQ, Kim M, Song Y, Hong YH, Lee DH, Song J. 2010. Molecular and biochemical characterization of the GALT gene in Korean patients with galactose-1-phosphate uridyltransferase deficiency. Clin Chim Acta, 411(19-20):1506-1510   DOI
26 Kotb MA, Mansour L, Shamma RA. 2019. Screening for galactosemia: Is there a place for it? Int. J. Gen. Med., 12:193   DOI
27 Banford S, Timson DJ. 2020 The structural and molecular biology of type IV galactosemia. Biochim., 183:13-17   DOI
28 Berry GT, Moate PJ, Reynolds RA, Yager CT, Ning C, Boston RC, Segal S. 2004. The rate of De Novo Galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency. Mol. Genet. Metab., 81(1):22-30   DOI
29 Lambert C, Boneh A. 2004. The impact of galactosaemia on quality of life-a pilot study. J. Inherit. Metab. Dis., 27(5):601-608   DOI
30 Lee JH. 2020. Phenylketonuria: current treatments and future developments. J. Korean Soc. Inherit. Metab. Dis., 20(2):37-43
31 European Galactosaemia Society. About Galactosemia. https://www.galactosaemia.eu/about-galactosaemia/, [accessed 2021.02.28]